Ph.D. William Benton Jones - 04 Jun 2025 Form 4 Insider Report for Corvus Pharmaceuticals, Inc. (CRVS)

Role: SVP, Pharmaceutical Development
Signature: /s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D.
Issuer symbol: CRVS
Transactions as of: 04 Jun 2025
Net transactions value: +$67,750
Form type: 4
Filing time: 06 Jun 2025, 16:26:07 UTC
Previous filing: 23 Dec 2024
Next filing: 08 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Jones William Benton	SVP, Pharmaceutical Development	C/O CORVUS PHARMACEUTICALS, INC., 901 GATEWAY BOULEVARD, THIRD FLOOR, SOUTH SAN FRANCISCO	/s/ Leiv Lea, as Attorney-in-Fact for William Benton Jones, Ph.D.	06 Jun 2025	0001664506

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CRVS	Common Stock	Options Exercise	$67,750	+19,357	+13%	$3.50	173,130	04 Jun 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CRVS	Warrant (Right to Buy)	Options Exercise		-19,357	-100%		0	04 Jun 2025	Common Stock	19,357	$3.50	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Issued at no additional consideration to the Reporting Person in connection with their subscription for shares of the Issuer's Common Stock at a price of $1.7312 per share.

Remarks:

SVP, Pharmaceutical Development